JP2012500197A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500197A5
JP2012500197A5 JP2011523005A JP2011523005A JP2012500197A5 JP 2012500197 A5 JP2012500197 A5 JP 2012500197A5 JP 2011523005 A JP2011523005 A JP 2011523005A JP 2011523005 A JP2011523005 A JP 2011523005A JP 2012500197 A5 JP2012500197 A5 JP 2012500197A5
Authority
JP
Japan
Prior art keywords
compound
cancer
cells
cell
rassf1a
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011523005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500197A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/004681 external-priority patent/WO2010019271A1/en
Publication of JP2012500197A publication Critical patent/JP2012500197A/ja
Publication of JP2012500197A5 publication Critical patent/JP2012500197A5/ja
Pending legal-status Critical Current

Links

JP2011523005A 2008-08-15 2009-08-14 Ｒａｓｓｆ１ａ発現およびヒト癌細胞増殖の蛍光調節剤 Pending JP2012500197A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18905908P 2008-08-15 2008-08-15
US61/189,059 2008-08-15
PCT/US2009/004681 WO2010019271A1 (en) 2008-08-15 2009-08-14 Fluorescent regulators of rassf1a expression and human cancer cell proliferation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014105150A Division JP2014148545A (ja) 2008-08-15 2014-05-21 Ｒａｓｓｆ１ａ発現およびヒト癌細胞増殖の蛍光調節剤

Publications (2)

Publication Number Publication Date
JP2012500197A JP2012500197A (ja) 2012-01-05
JP2012500197A5 true JP2012500197A5 (https=) 2013-05-09

Family

ID=41279343

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011523005A Pending JP2012500197A (ja) 2008-08-15 2009-08-14 Ｒａｓｓｆ１ａ発現およびヒト癌細胞増殖の蛍光調節剤
JP2014105150A Pending JP2014148545A (ja) 2008-08-15 2014-05-21 Ｒａｓｓｆ１ａ発現およびヒト癌細胞増殖の蛍光調節剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014105150A Pending JP2014148545A (ja) 2008-08-15 2014-05-21 Ｒａｓｓｆ１ａ発現およびヒト癌細胞増殖の蛍光調節剤

Country Status (9)

Country Link
US (1) US10457639B2 (https=)
EP (2) EP2323982B1 (https=)
JP (2) JP2012500197A (https=)
CN (1) CN102186820B (https=)
AT (1) ATE547403T1 (https=)
AU (1) AU2009282451B2 (https=)
BR (1) BRPI0917411A2 (https=)
CA (1) CA2734225A1 (https=)
WO (1) WO2010019271A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
ES2641642T3 (es) 2010-03-08 2017-11-10 Monsanto Technology Llc Moléculas de polinucleótido para regulación génica en plantas
US8637679B2 (en) 2011-03-11 2014-01-28 Council Of Scientific And Industrial Research Process for the isolation of organic compounds useful for the treatment of cancer
EP3382027A3 (en) 2011-09-13 2018-10-31 Monsanto Technology LLC Methods and compositions for weed control
WO2013040057A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
CA2848695A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and composition for weed control comprising inhibiting ppg oxidase
MX348495B (es) 2011-09-13 2017-06-14 Monsanto Technology Llc Metodos y composiciones para el control de malezas.
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
MX361938B (es) 2011-09-13 2018-12-19 Monsanto Technology Llc Métodos y composiciones para el control de malezas.
MX360866B (es) 2012-05-24 2018-11-09 A B Seeds Ltd Composiciones y métodos para silenciar la expresión genética.
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
UY35252A (es) 2013-01-01 2014-07-31 Seeds Ltd Ab MÉTODOS PARA INTRODUCIR dsRNA EN SEMILLAS DE PLANTAS PARA MODULAR LA EXPRESIÓN GENÉTICA
BR112015023051A2 (pt) 2013-03-13 2017-11-14 Monsanto Technology Llc método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
US10612019B2 (en) 2013-03-13 2020-04-07 Monsanto Technology Llc Methods and compositions for weed control
WO2014151317A1 (en) * 2013-03-15 2014-09-25 Rush University Medical Center Methods for treating cancer
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
EP3030663B1 (en) 2013-07-19 2019-09-04 Monsanto Technology LLC Compositions and methods for controlling leptinotarsa
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
AU2014341879B2 (en) 2013-11-04 2020-07-23 Greenlight Biosciences, Inc. Compositions and methods for controlling arthropod parasite and pest infestations
UA119253C2 (uk) 2013-12-10 2019-05-27 Біолоджикс, Інк. Спосіб боротьби із вірусом у кліща varroa та у бджіл
WO2015108982A2 (en) 2014-01-15 2015-07-23 Monsanto Technology Llc Methods and compositions for weed control using epsps polynucleotides
WO2015153339A2 (en) 2014-04-01 2015-10-08 Monsanto Technology Llc Compositions and methods for controlling insect pests
CN106795515B (zh) 2014-06-23 2021-06-08 孟山都技术公司 用于经由rna干扰调控基因表达的组合物和方法
US11807857B2 (en) 2014-06-25 2023-11-07 Monsanto Technology Llc Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
CN106604993A (zh) 2014-07-29 2017-04-26 孟山都技术公司 用于控制昆虫害虫的组合物和方法
CN108064288B (zh) 2015-01-22 2021-11-26 孟山都技术公司 用于控制叶甲属的组合物和方法
EP3302053B1 (en) 2015-06-02 2021-03-17 Monsanto Technology LLC Compositions and methods for delivery of a polynucleotide into a plant
WO2016196782A1 (en) 2015-06-03 2016-12-08 Monsanto Technology Llc Methods and compositions for introducing nucleic acids into plants
WO2017023916A1 (en) 2015-08-05 2017-02-09 Georgetown University Small molecule androgen receptor inhibitors and methods of use thereof
JP7236382B2 (ja) * 2017-06-12 2023-03-09 昇平 宮田 抗癌剤及びその使用
CN107266356B (zh) * 2017-07-25 2020-06-26 山西省生物研究院有限公司 一种作为自分泌运动因子抑制剂的咔唑类化合物及其制备方法和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2235815A1 (de) * 1972-07-21 1974-01-31 Bayer Ag Polyazofarbstoffe
EP0545913B1 (en) 1986-08-18 1999-02-24 Emisphere Technologies, Inc. Delivery systems for pharmacological agents
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU643141B2 (en) 1991-03-15 1993-11-04 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
GB9215361D0 (en) 1992-07-20 1992-09-02 Wellcome Found Heterocyclic compounds
US5834462A (en) * 1993-07-26 1998-11-10 Eisai Co., Ltd. Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives
JP3690825B2 (ja) * 1993-07-26 2005-08-31 エーザイ株式会社 三環式ヘテロ環含有スルホンアミドおよびスルホン酸エステル誘導体
CA2186412A1 (en) * 1995-10-31 1997-05-01 Katherine S. Takaki Ethylamino carbazole melatonergic agents
JP3887769B2 (ja) 1997-12-22 2007-02-28 バイエル コーポレイション 対称および非対称ジフェニル尿素を用いるｐ３８キナーゼの阻害
WO2000063171A1 (en) * 1999-04-20 2000-10-26 Meiji Seika Kaisha, Ltd. Tricyclic compounds
KR20020069215A (ko) 1999-12-16 2002-08-29 아사히 가세이 가부시키가이샤 신규한 치환기를 갖는 3환성 화합물
AU2001252575A1 (en) 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
US6506901B2 (en) 2000-07-17 2003-01-14 Wyeth Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
KR20090090406A (ko) * 2000-12-18 2009-08-25 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 염증성 사이토카인 생산 유리 억제제
WO2002060867A2 (en) * 2001-01-29 2002-08-08 Insight Strategy And Marketing Ltd Carbazole derivatives and their uses as heparanase inhibitors
JPWO2002074306A1 (ja) 2001-03-19 2004-07-08 旭化成ファーマ株式会社 脂肪肝治療薬
GB0319151D0 (en) 2003-08-14 2003-09-17 Glaxo Group Ltd Novel compounds
US20100063126A1 (en) 2004-06-29 2010-03-11 Jadolabs Gmbh Carbazole-Derived Pharmaceutical Compositions
WO2006018405A1 (en) 2004-08-18 2006-02-23 Ciba Specialty Chemicals Holding Inc. Oxime ester photoinitiators
ITMI20051523A1 (it) 2005-08-03 2007-02-04 Acraf Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
DE112006002340T5 (de) 2005-09-01 2008-07-17 Council Of Scientific And Industrial Research Arzneimittel, verwendbar zur Behandlung von Prostatakrebs
CN1807413B (zh) * 2005-09-28 2010-05-05 中国医学科学院医药生物技术研究所 咔唑磺酰胺衍生物及其制备方法
NZ567266A (en) 2005-10-13 2010-09-30 Orchid Res Lab Ltd Carbazole derivatives as pSTAT3/IL-6 inhibitors (carvedilol)
US20100130579A1 (en) * 2006-10-23 2010-05-27 Georgetown University Cancer therapy
IL186935A0 (en) * 2006-10-31 2008-02-09 Veridex Llc Prostate cancer field effect analysis methods and kits
AU2008345036A1 (en) * 2007-12-28 2009-07-09 John Wayne Cancer Institute Use of methylation status of MINT loci and tumor-related genes as a marker for melanoma and breast cancer
WO2009118292A1 (en) 2008-03-24 2009-10-01 Novartis Ag Arylsulfonamide-based matrix metalloprotease inhibitors

Similar Documents

Publication Publication Date Title
JP2012500197A5 (https=)
US9138418B2 (en) Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles
ES2665539T3 (es) Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1
NZ588583A (en) Novel lipid formulations for nucleic acid delivery
Sun et al. Anti-miRNA oligonucleotide therapy for chondrosarcoma
US20220048908A1 (en) Compositions and methods for modulating hair growth
JP2019511491A5 (https=)
EP3791897A1 (en) Hsp90 inhibitor drug conjugates
US20200369710A1 (en) Rna nanostructures, methods of making, and uses thereof
US20110034545A1 (en) Double-stranded lipid-modified rna having high rna interference effect
JP2021502346A5 (https=)
US20200108089A1 (en) Gemcitabine Derivatives for Cancer Therapy
MY157187A (en) Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
Solórzano et al. Versatile iron–catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy
US20220372493A1 (en) Rna nanoparticle for liver cancer treatment
WO2017193460A1 (zh) 一种基于金纳米簇联合NGF siRNA治疗胰腺癌的方法
JP2025507982A (ja) 活性分子送達に利用可能な分解性リポソーム及びそのナノ複合体
US20230358726A1 (en) Non-invasive functional companion assays for oncogene targeted therapy for brain cancer
Srinivas The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challenges
US20240115596A1 (en) Compositions and methods for treating sars-cov-2 infection
JP2024063189A (ja) 血液脳関門透過能を有するペプチド核酸複合体及びこれを含む組成物
TW201620504A (zh) 局部投與用脂質複合體之新穎製造方法及使用該脂質複合體之抗腫瘤劑
US20240035035A1 (en) Compositions and methods for treating, ameliorating, and/or preventing viral infections
JP2012516830A (ja) 医薬物質としてのアミノ酸誘導体
US20250082765A1 (en) Molecules as anticancer agents for targeted treatment of breast and prostate cancer